Not applicableUnknownNCT06066814
What this trial is testing
To Study the Role of Plasma Von Willebrand Factor Antigen (vWF) to A Disintegrin-like and Metalloproteinase With Thrombospondin Type-1 Motifs 13 (ADAMTS-13) Activity Ratio as a Predictor of Development of Extrahepatic Organ Failure in Acute on Chronic Liver Failure (ACLF) Patients.
Who this might be right for
Acute on Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 50